STSA

Satsuma Pharmaceuticals, Inc. Common Stock

Delisted

STSA was delisted on the 7th of June, 2023.

48 hedge funds and large institutions have $49.5M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
13
Reduced
15
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
B
51
Bailard
California
-$150K -38,600 Closed
AIM
52
Alambic Investment Management
California
-$81K -20,711 Closed
Jane Street
53
Jane Street
New York
-$76K -19,640 Closed
QSS
54
Quantitative Systematic Strategies
Florida
-$55K -14,195 Closed
CPIG
55
Chicago Partners Investment Group
Illinois
-$52K -14,081 Closed
BAM
56
Blueshift Asset Management
New Jersey
-$39K -10,143 Closed
ED
57
Exane Derivatives
France
-$15.9K -4,078 Closed
PFS
58
Prospera Financial Services
Texas
-$4K -1,139 Closed